129 related articles for article (PubMed ID: 20978389)
1. Role of biomarkers in predicting CVD risk in the setting of HIV infection?
Worm SW; Hsue P
Curr Opin HIV AIDS; 2010 Nov; 5(6):467-72. PubMed ID: 20978389
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers for cardiovascular disease: challenges and future directions.
May A; Wang TJ
Trends Mol Med; 2008 Jun; 14(6):261-7. PubMed ID: 18487087
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress biomarkers as predictors of cardiovascular disease.
Strobel NA; Fassett RG; Marsh SA; Coombes JS
Int J Cardiol; 2011 Mar; 147(2):191-201. PubMed ID: 20864194
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers and HIV-associated cardiovascular disease.
Baker JV; Duprez D
Curr Opin HIV AIDS; 2010 Nov; 5(6):511-6. PubMed ID: 20978394
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular manifestations of pediatric HIV infection.
Lane-McAuliffe EM; Lipshultz SE
Nurs Clin North Am; 1995 Jun; 30(2):291-316. PubMed ID: 7777409
[TBL] [Abstract][Full Text] [Related]
6. A consultation-based method is equal to SCORE and an extensive laboratory-based method in predicting risk of future cardiovascular disease.
Petersson U; Ostgren CJ; Brudin L; Nilsson PM
Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):536-40. PubMed ID: 19357517
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the role of biomarkers for cardiovascular risk prediction: focus on CRP, BNP and urinary microalbumin.
May A; Wang TJ
Expert Rev Mol Diagn; 2007 Nov; 7(6):793-804. PubMed ID: 18020909
[TBL] [Abstract][Full Text] [Related]
8. Developing and assessing cardiovascular biomarkers.
Dadu RT; Nambi V; Ballantyne CM
Transl Res; 2012 Apr; 159(4):265-76. PubMed ID: 22424430
[TBL] [Abstract][Full Text] [Related]
9. Is estimated cardiovascular risk higher in HIV-infected patients than in the general population?
De Socio GV; Martinelli L; Morosi S; Fiorio M; Roscini AR; Stagni G; Schillaci G
Scand J Infect Dis; 2007; 39(9):805-12. PubMed ID: 17701720
[TBL] [Abstract][Full Text] [Related]
10. Cardiac biomarkers in persons with HIV infection: a review of the literature.
Chandler C; Dorsen C
J Assoc Nurses AIDS Care; 2014; 25(1):83-91. PubMed ID: 23478050
[No Abstract] [Full Text] [Related]
11. Update on cardiovascular complications in HIV infection.
Currier JS
Top HIV Med; 2009; 17(3):98-103. PubMed ID: 19675367
[TBL] [Abstract][Full Text] [Related]
12. Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium score.
Mangili A; Gerrior J; Tang AM; O'Leary DH; Polak JK; Schaefer EJ; Gorbach SL; Wanke CA
Clin Infect Dis; 2006 Dec; 43(11):1482-9. PubMed ID: 17083026
[TBL] [Abstract][Full Text] [Related]
13. Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus.
Beltrán LM; Rubio-Navarro A; Amaro-Villalobos JM; Egido J; García-Puig J; Moreno JA
Vasc Health Risk Manag; 2015; 11():35-48. PubMed ID: 25609975
[TBL] [Abstract][Full Text] [Related]
14. Increased cardiovascular risk in HIV infection: drugs, virus and immunity.
Murphy R; Costagliola D
AIDS; 2008 Aug; 22(13):1625-7. PubMed ID: 18670222
[No Abstract] [Full Text] [Related]
15. Multiple biomarkers for predicting cardiovascular events: lessons learned.
Wang TJ
J Am Coll Cardiol; 2010 May; 55(19):2092-5. PubMed ID: 20447531
[No Abstract] [Full Text] [Related]
16. Hyperhomocysteinaemia in HIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease.
Guaraldi G; Ventura P; Garlassi E; Orlando G; Squillace N; Nardini G; Stentarelli C; Zona S; Marchini S; Moriondo V; Tebas P
HIV Med; 2009 Jan; 10(1):28-34. PubMed ID: 19125962
[TBL] [Abstract][Full Text] [Related]
17. Gap analysis of pediatric reference intervals for risk biomarkers of cardiovascular disease and the metabolic syndrome.
Mansoub S; Chan MK; Adeli K
Clin Biochem; 2006 Jun; 39(6):569-87. PubMed ID: 16624272
[TBL] [Abstract][Full Text] [Related]
18. Angiopoietin-2 levels as a biomarker of cardiovascular risk in patients with hypertension.
Patel JV; Lim HS; Varughese GI; Hughes EA; Lip GY
Ann Med; 2008; 40(3):215-22. PubMed ID: 18382887
[TBL] [Abstract][Full Text] [Related]
19. Combining serum biomarkers: the association of C-reactive protein, insulin sensitivity, and homocysteine with cardiovascular disease history in the general US population.
Cummings DM; King DE; Mainous AG; Geesey ME
Eur J Cardiovasc Prev Rehabil; 2006 Apr; 13(2):180-5. PubMed ID: 16575270
[TBL] [Abstract][Full Text] [Related]
20. The role of iron in HIV infection and its related cardiovascular complications.
Mascitelli L; Goldstein MR
J Cardiovasc Med (Hagerstown); 2014 Dec; 15(12):883-4. PubMed ID: 25353975
[No Abstract] [Full Text] [Related]
[Next] [New Search]
